SENORES PHARMACEUTICALS L (SENORES)

NSE: ₹1,044.40
BSE: ₹1,042.95
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 9.59 11.86 19.82 35.33 28.76 36.81 26.99
YOY Revenue Growth % - - - - 199.93% 210.37% 36.18%
Other Income 7.19 9.25 8.39 11.36 9.78 22.19 9.55
Total Income 16.78 21.11 28.21 46.69 38.54 59.00 36.54
Total Expenses + 15.46 18.21 24.62 39.04 35.02 46.31 35.15
Cost of Materials Consumed 1.83 2.81 1.40 1.00 3.78 18.36 7.47
Employee Benefit Expense 4.92 4.45 6.91 11.59 9.16 11.12 10.10
Other Expenses 1.78 3.41 6.92 10.59 8.16 5.65 7.07
Operating Profit -5.87 -6.35 -4.80 -3.71 -6.26 -9.50 -8.16
OPM % -61.2% -53.5% -24.2% -10.5% -21.8% -25.8% -30.2%
Profit Before Tax + 1.32 2.90 3.59 7.65 3.52 12.69 1.39
Tax Expense 0.25 0.88 0.89 1.22 0.87 4.21 0.36
Tax % 18.6% 30.3% 24.8% 15.9% 24.7% 33.2% 25.9%
Profit After Tax 1.08 2.02 2.70 6.43 2.65 8.48 1.03
EPS (Basic) 0.32 0.39 0.59 1.40 1.98 1.84 0.22

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 106.09 38.54
YOY Revenue Growth % 175.27% -
Other Income 66.35 21.99
Total Income 172.44 60.53
Total Expenses + 144.98 55.42
Cost of Materials Consumed 24.55 7.26
Employee Benefit Expense 38.78 18.25
Other Expenses 31.32 9.74
Operating Profit -38.89 -16.88
OPM % -36.7% -43.8%
Profit Before Exceptional 27.46 5.11
Exceptional Items 0.00 0.00
Profit Before Tax + 27.46 5.11
Tax Expense 7.21 1.42
Tax % 26.3% 27.8%
Profit After Tax 20.25 3.69
EPS (Basic) 4.40 1.02

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 632.27 422.01
Property, Plant & Equipment 97.92 46.23
Capital Work in Progress 8.54 34.01
Non-Current Investments 154.48 104.38
Goodwill 0.00 0.00
Other Intangible Assets 0.01 0.02
Current Assets + 255.64 412.08
Inventories 9.75 8.66
Trade Receivables 76.46 25.69
Cash and Cash Equivalents 32.22 81.20
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 749.90 707.96
Equity Share Capital 46.05 46.05
Other Equity 703.85 661.91
Non-Current Liabilities 68.45 84.90
Current Liabilities 69.56 41.23
Total Liabilities 138.01 126.13

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities -26.88 -20.40
Cash from Investing Activities -19.46 -162.93
Cash from Financing Activities -2.64 532.62
Net Increase/Decrease in Cash -48.98 349.29